Qlife (Group)

https://www.qlifeholding.com

Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement. Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se). *

	Start	2019-01-01 existent
	Today	Qlife Holding AB
	Industry	diagnostic test, blood-based
	Industry 2	diagnostic test, rapid (point-of-care)
	Person	Warthoe, Thomas (Qlife 202011 CEO)
	Person 2	Rousøe, Kasper Damgaard (Qlife 202203– CFO before Phase One A/S + Bauer Media Group + Mono Solutions + Designit A/S)

	Region	Helsingborg
	Country	Sweden
	Street	48 Redegatan
	City	25236 Helsingborg
		Address record changed: 2021-11-29

Basic data	Employees	n. a.

		* Document for »About Section«: Qlife Holding AB. (11/29/21). "Press Release: Qlife Recruits Kasper Damgaard Rousøe as New Chief Financial Officer".

		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)